- Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. The Lancet. Oncology. 2017 Academic Article GET IT
- Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2016 Academic Article GET IT
- The evolving field of prognostication and risk stratification in MDS: Recent developments and future directions. Blood Reviews. 2016 Information Resource GET IT
- Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey. Clinical lymphoma, myeloma & leukemia. 2015 Academic Article GET IT
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.
Journal of the National Comprehensive Cancer Network : JNCCN.
Times cited: 10
- Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium. Leukemia research. 2012 Information Resource GET IT